Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cheng Ren

Showing results (321-330 of 322) with videos related to

Pageof 33
Sort By:
You have reached the last page of results.This site can display upto 322 results.
Frontiers in Oncology|April 1, 2022
CRMP4 CpG Hypermethylation Predicts Upgrading to Gleason Score ≥ 8 in Prostate CancerXiao-Ping Qin, Qi-Ji Lu, Cheng-Huizi Yang, et al.
Asian Journal of Andrology|May 1, 2015
Percent free prostate-specific antigen is effective to predict prostate biopsy outcome in Chinese men with prostate-specific antigen between 10.1 and 20.0 ng ml(-1)Rui Chen, Li-Qun Zhou, Xiao-Bing Cai, et al.
Pageof 33

Showing results (321-330 of 322) with videos related to

Sort By:
Pageof 33
You have reached the last page of results.This site can display upto 322 results.
Frontiers in Oncology|April 1, 2022
CRMP4 CpG Hypermethylation Predicts Upgrading to Gleason Score ≥ 8 in Prostate CancerXiao-Ping Qin, Qi-Ji Lu, Cheng-Huizi Yang, et al.
Asian Journal of Andrology|May 1, 2015
Percent free prostate-specific antigen is effective to predict prostate biopsy outcome in Chinese men with prostate-specific antigen between 10.1 and 20.0 ng ml(-1)Rui Chen, Li-Qun Zhou, Xiao-Bing Cai, et al.
Pageof 33